- The share
- Press releases
- Financial calendar
- Financial reports
- Prospectus and material offerings
- Financial presentations
- Corporate governance
- Analyst Coverage
- CODE OF CONDUCT
- Thank you
XVIVO Perfusion changes the date of reporting of the interim report January – June 2018 to July 20, 2018
Due to administrative reasons, XVIVO Perfusion AB (publ) has decided to change the date of reporting of the interim report January – June 2018 to July 20, 2018.
June 14, 2018
Magnus Nilsson, CEO
XVIVO Perfusion AB (publ)
For further information please contact:
Christoffer Rosenblad, CFO, +46 735 192159, email@example.com
Magnus Nilsson, CEO, +46 31 788 2150, firstname.lastname@example.org
For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com
The information was submitted for publication, through the agency of the contact person set out above, at 8:00 pm CET on June 14, 2018.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.